#RoVi hashtag - Bluesky

@victorribera.bsky.social

2 months ago

VesselAlert Vaixell
Nom del Vaixell: ROVI
MMSI: 224219420
Indicatiu: 336618
Tipus: Veler
Bandera: Espanya
Vist a: 16-Jan-2026 14:50:17 CET
Velocitat: 5.3 kts
Distància: 7.7 nm
Senyal RSSI: -14.2 dBFS
Vaixell AIS VesselAlert © kx1t - kx1t - aiscatcher - sdr-e

0 0 0 0

@aisfriesland.bsky.social

2 months ago

VesselAlert
Name: ROVI
MMSI: 244030466
Callsign: OT5309
Flag: Netherlands
Seen: 15-Jan-2026 18:15:01 CET
Status: under way using engine
Speed: 8.1 kts
Dest.: GENEMUIDEN
Distance: 66.5 nm
Signal RSSI: 0.0 dBFS
Ship AIS VesselAlert © kx1t - link

0 0 0 0

Aldrine Joseph 25 🇵🇭

@aldrinejoseph25.bsky.social

7 months ago

Macrovision (1997-2007) logo remake
#Macrovision #Rovi #Tixo #Xperi

Watch it on YouTube:
www.youtube.com/watch?v=zcVO...
Download the file here:
drive.google.com/drive/folder...
www.mediafire.com/file/2mg2tfr...

6 1 0 0

Profit Trading USA

@profittradingusa.bsky.social

8 months ago

Laboratorios Farmaceuticos Rovi reports Q2 results, reiterates outlook Investing.com -- Spanish pharmaceutical company Laboratorios Farmaceuticos Rovi on Thursday reported first-half 2025 results in line with sales consensus and 4% above consensus at the EBITDA level. The company posted a 4.5% sales decline in the first half of the year to €314.6 million, aligning with its guidance of a "low-single-digit decline." This decrease was primarily driven by a contraction in the Contract Development and Manufacturing Organization (CDMO) business, which fell 35.1% to €77.2 million compared to €118.9 million in the same period last year. The CDMO revenue decline was attributed to lower contributions from mRNA products and a temporary closure of the Madrid facility for regulatory upgrades, which resulted in revenue shifting from the first quarter of 2025 to the fourth quarter of 2024. Despite the overall sales decline, Rovi’s specialty pharmaceutical business grew by 12.8% to €237.4 million, with particularly strong performance from its low-molecular-weight heparin (LMWH) products, which increased by 12% in the first half. The company’s gross margin improved to 62.4% from 59.4% in the first half of 2024, exceeding the consensus estimate of 61.0%. This improvement was driven by increased contribution from Okedi, which has high margins, and a 33% decrease in LMWH raw material prices. EBITDA decreased 6.2% to €65.6 million, though this was still above the consensus estimate of €63.1 million. The EBITDA margin contracted to 20.9% from 21.2% in the same period last year, primarily due to increased R&D spending. Rovi reiterated its full-year 2025 guidance, expecting a mid-single-digit percentage decline in operating revenue compared to 2024. However, the company raised its outlook for enoxaparin, now projecting a mid-single-digit increase for the year, an improvement from its previous forecast of a low-single-digit decrease. The company also confirmed it remains on track with its clinical programs, with Phase III trials for Letrozole SIE and clinical programs for Risperidone QUAR both set to begin in the fourth quarter of 2025. Despite near-term challenges in its CDMO business, Rovi maintained its medium-term guidance to double CDMO sales to approximately €700 million by 2030. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C. Before you buy stock in ROVI, consider this: ProPicks AI are 6 easy-to-follow model portfolios created by Investing.com for building wealth by identifying winning stocks and letting them run. Over 150,000 paying members trust ProPicks to find new stocks to buy – driven by AI. The ProPicks AI algorithm has just identified the best stocks for investors to buy now. The stocks that made the cut could produce enormous returns in the coming years. Is ROVI one of them?

Click Subscribe #Rovi #ResultadosQ2 #Farmacéutica #Inversión #MercadosFinancieros

0 0 0 0

Ben Ciara Bo Addie Brady Weston

@teamcinrovidays.bsky.social

9 months ago

#RobertScottWilson #RobWilson #VictoriaKonefal #BenWeston #CiaraBrady #CiaraWeston #Cin #RoVi #BringBackCin #Days #DOOL #DaysofourLives @dayspeacock.bsky.social @soapcentral.bsky.social

2 2 1 0

Massimo Marciano

@massimomarciano.bsky.social

9 months ago

FLASH NEWS - metropoli.online Il tuo browser non supporta l’iframe Per ricevere via e-mail news e aggiornamenti degli articoli pubblicati:

#Roma: #corpo di #bimba di 5 mesi trovato in un parco

Alcuni #passanti lo hanno notato tra i #rovi a #VillaPamphili e hanno avvisato #polizia e #carabinieri. Segni di #traumi su mano destra e braccio

www.metropoli.online/flash-news/

0 0 0 0

Ben Ciara Bo Addie Brady Weston

@teamcinrovidays.bsky.social

11 months ago

#RobertScottWilson #RobWilson #VictoriaKonefal #BenWeston #CiaraBrady #CiaraWeston #Cin #RoVi #BringBackCin #Days #DOOL #DaysofourLives @dayspeacock.bsky.social @soapoperadigest.bsky.social

2 2 1 0

Cronache della Campania

@cronachecampania.bsky.social

1 year ago

Lo chef Antonio Tecchia ospite dell’ultima serata di “Metti una sera a cena…”, al Ro.Vi di Ercolano È un appuntamento molto atteso quello di giovedì 27 marzo da RoVi, ad Ercolano; è l’ultimo, infatti, della prima edizione della fortunata rassegna “Metti una sera a cena…”, che ha visto avvicendarsi, nel locale di Vincenzo Damiano e Rocco Campana, chef stellati e maestri pasticceri. Ad affiancare Damiano, in cucina,...

#ChefAntonioTecchia #MettiUnaSeraACena #RoVi #Ercolano #CucinaItaliana

0 0 0 0

INFAGA

@infaga.bsky.social

1 year ago

🚀 Rovi sube tras anunciar planes ambiciosos

📅 Día del Inversor 2025
📈 Ingresos x1.8 y EBITDA x2.8 en 2030
💼 CDMO será el motor clave de crecimiento
#Rovi #Bolsa #Inversión (1/2)